ELITE PHARMS INC by Elite Pharmaceuticals, Inc. Financials - Benzinga

ELITE PHARMS INC by Elite Pharmaceuticals, Inc.

ELTPOTCQB

Trade with Public

Trade with Public

$0.3100

-0.0485-13.53%

At close: Aug 14, 5:00 PM EST

Earnings: Q1 2027 Earnings were released on Thu Aug 13th, after the market close

Overview News Earnings ForecastFinancialsSentiment Ownership Compare

ELITE PHARMS INC by Elite Pharmaceuticals, Inc. Financials

ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Elite Pharmaceuticals Q4 EPS $0.01 Down From $0.02 YoY, Sales $40.748M Up From $31.996M YoY

Elite Pharmaceuticals (OTC:ELTP) reported quarterly earnings of $0.01 per share. This is a 50 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $40.748 million in

Benzinga Newsdesk

PRO
Elite Pharmaceuticals Q3 EPS $0.01 Up From $(0.01) YoY, Sales $31.589M Up From $14.364M YoY

Elite Pharmaceuticals (OTC:ELTP) reported quarterly earnings of $0.01 per share. This is a 200 percent increase over losses of $(0.01) per share from the same period last year. The company reported $31.589 million in

Benzinga Newsdesk

PRO
Elite Pharmaceuticals Q1 EPS $(0.01), Sales $40.211M Up From $18.803M YoY

Elite Pharmaceuticals (OTC:ELTP) reported quarterly losses of $(0.01) per share. The company reported $40.211 million in sales this quarter. This is a 113.85 percent increase over sales of $18.803 million the same

Benzinga Newsdesk

PRO
Elite Pharmaceuticals Q3 EPS $(0.01), Sales $14.36M Down From $15.54M YoY

Elite Pharmaceuticals (OTC:ELTP) reported quarterly losses of $(0.01) per share. The company reported $14.36 million in sales this quarter. This is a 7.56 percent decrease over sales of $15.54 million the same period

Benzinga Newsdesk

PRO
Elite Pharmaceuticals Q1 Sales $8.98M Up From $7.67M YoY

Elite Pharmaceuticals (OTC:ELTP) reported $8.98 million in sales this quarter. This is a 17.03 percent increase over sales of $7.67 million the same period last year.

Benzinga Newsdesk

Elite Pharmaceuticals Q3 Sales $9.25M Up From $8.97M YoY

Elite Pharmaceuticals (OTC:ELTP) reported $9.25 million in sales this quarter. This is a 3.06 percent increase over sales of $8.97 million the same period last year.

Michael Horton